October 31, 2016 7:02am
… Bracing for quarterly reporting and another market moving “matter” – political uncertainty
For sector equities with Election Day a little more than a week away, investors were served a reminder that politics remains a potential source of volatility
I answer one question; in which company should investors put, keep and commit their money!
If you are not a subscriber, you won’t know the morning’s indications and who is in the headlights.
I write in every line that investors need to avoid risks as if I were the first to be hurt if I am wrong!
RegMed Investors’ (RMi) provides exclusive and original content; put your eyes on the page to figure out what’s really going on!
Indexes and ETFs: The IBB (+0.39%) is UP while the IWM, XBI and XLV are NOT indicating
Dow futures are UP +0.04% and NASDAQ futures are UP +0.28%
U.S. stock index futures pointed to a slightly higher open on Monday, as investors prepared for more earnings and data, amid uncertainty surrounding the U.S. election and what the Federal Reserve might do next.
European markets started the week lower as revelations over the weekend increased uncertainty over the upcoming U.S. presidential election.
Asian markets were mostly lower, as a triple-whammy of concerns over the upcoming U.S. presidential election, weak Japanese data and lower oil prices weighed on sentiment.
Data docket: Personal income and consumer spending are due out at 8.30 a.m. ET, while Chicago PMI is due out at 9.45 a.m. ET.
The stem, cell, gene and regenerative therapy (SCG&RT) sector closed NEGATIVE on Friday, Thursday, Wednesday, Tuesday and last Monday.
The SCG&RT sector’s record after the last 5 days (of 43 covered companies):
· Friday closed NEGATIVE with 22 decliners, 16 advancers and 5 flats;
· Thursday closed NEGATIVE with 30 decliners, 10 advancers and 3 flats;
· Wednesday closed NEGATIVE with 28 decliners, 14 advancers and 1 flat;
· Tuesday closed NEGATIVE with 28 decliners, 9 advancers and 6 flats;
· Last Monday closed NEGATIVE with 27 decliners, 10 advancers and 6 flats;
Remembering Friday’s closing post, “I perceive that we will be seeing more of … a tug of war between Q3 reporting of cash positions and share pricing – it will be all about … runways.”
The SCG&RT sector is rotating even further down after six days, with an analogy to – no news is good news and bad news has been sold into.
- With Election Day a little more than a week away, investors were served a reminder that politics remains a potential source of volatility.
The stock market, which had been gripped in lethargy, got a jolt Friday from a political curve-ball when the Federal Bureau of Investigation (FBI) revealed it would review newly discovered emails related to Hillary Clinton’s private email server.
You’ve made it to the office, turned on the monitor, having just gotten your coffee and it hits you - what could be today’s trades?
Watch list:
· The iShares Nasdaq Biotechnology (IBB) closed Friday down -1.88% and is UP +0.39% in Monday’s pre-market;
· The SPDR S&P Biotech ETF (XBI) closed Friday down -0.51% and is NOT indicating in Monday pre-market;
· The Health Care Select Sector SPDR ETF (XLV) closed down -2.17% Friday and is NOT indicating in Monday’s pre-market;
· The iShares Russell 2000 (IWM) closed down -0.28% on Friday and is NOT indication in Monday’s pre-market.
Companies in my headlights:
· I abstain from individual prognostication - today - for only the second time in many years;
· However, I believe many sector equities are OVERSOLD … as quarterly reporting season gets going …
Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.
Henry’s comments are for informational purposes only and are not a substitute for personalized advice. Consult your advisor about what is best for you.
